These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18788991)

  • 1. Health practices and vaginal microbicide acceptability among urban black women.
    Reiff M; Wade C; Chao MT; Kronenberg F; Cushman LF
    J Womens Health (Larchmt); 2008 Oct; 17(8):1345-51. PubMed ID: 18788991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.
    Han L; Lv F; Xu P; Zhang G; Juniper NS; Wu Z
    J Womens Health (Larchmt); 2009 Sep; 18(9):1377-84. PubMed ID: 19743909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
    Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
    Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
    Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
    Morrow KM; Underhill K; van den Berg JJ; Vargas S; Rosen RK; Katz DF
    Arch Sex Behav; 2014 Oct; 43(7):1459-67. PubMed ID: 24452632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
    Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD
    Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type.
    Morrow KM; Fava JL; Rosen RK; Christensen AL; Vargas S; Barroso C
    Health Psychol; 2007 Nov; 26(6):777-86. PubMed ID: 18020851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
    Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
    J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
    Hoel N; Shaikh S; Kagee A
    Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa.
    Harper CC; Holt K; Nhemachena T; Chipato T; Ramjee G; Stratton L; Blum M; McCulloch CE; Mgweba S; Blanchard K
    AIDS Behav; 2012 Oct; 16(7):1821-9. PubMed ID: 22210482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
    Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M
    Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.
    Cook RL; Downs JS; Marrazzo J; Switzer GE; Tanriover O; Wiesenfeld H; Murray PJ; Hillier SL
    J Womens Health (Larchmt); 2009 Aug; 18(8):1163-7. PubMed ID: 19630538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-framing microbicide acceptability: findings from the MDP301 trial.
    Montgomery CM; Gafos M; Lees S; Morar NS; Mweemba O; Ssali A; Stadler J; Pool R;
    Cult Health Sex; 2010 Aug; 12(6):649-62. PubMed ID: 20397079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
    Tanner AE
    SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.